Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492801 · ClinicalTrials.gov registry record
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
A clinical trial, sponsored by University of Southern California.
- Terminated
- Registry status
- 10
- Enrollment target
NCT03492801 is a clinical trial that was terminated before completion, run by University of Southern California. The registered enrollment target is 10 participants.
The verdict
NCT03492801 was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This pilot research trial studies the collection of blood samples in monitoring tumor specific mutations in patients with non-small cell lung cancer that has spread to other places in the body or cannot be removed by surgery. Collecting blood samples may help measure the changes in lung cancer, better learn methods to track cancer in the bloodstream, and improve cancer treatments.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-12-11 |
| Est. Completion | 2023-11-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03492801
The ClinicalTrials.gov registry entry for NCT03492801 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT03492801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03492801 about?
NCT03492801 is a clinical study titled "Collection of Blood Samples in Patients With Non-small Cell Lung Cancer". This pilot research trial studies the collection of blood samples in monitoring tumor specific mutations in patients with non-small cell lung cancer that has spread to other places in the body or cannot be removed by surgery. Collecting blood samples may help measure the changes in lung cancer, bett...
What is the current status of trial NCT03492801?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2017-12-11. Estimated completion is 2023-11-21.
What interventions are being tested in trial NCT03492801?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT03492801?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.